CVS Health Corporation (CVS) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	415.1B	402.1B	372.8B	357.8B	322.5B
Cost of Revenue	356.3B	346.7B	321.4B	303.3B	268.0B
Gross Profit	58.7B	55.4B	51.4B	54.4B	54.5B
Operating Expenses
R&D Expense	—	—	—	—	—
SG&A Expense	—	—	41.2B	—	—
General & Admin Expense	—	—	40.2B	—	—
Selling & Marketing Expense	—	—	989.0M	—	—
Other Expenses	50.5B	45.0B	1.7B	40.7B	46.5B
Total Operating Expenses	50.5B	45.0B	42.9B	40.7B	46.5B
Cost and Expenses	406.8B	391.7B	364.3B	344.0B	314.5B
Operating Income (EBIT)	8.3B	10.4B	8.5B	13.7B	8.0B
Non-Operating
Interest Income	—	—	—	—	—
Interest Expense	3.1B	3.1B	3.0B	2.7B	2.3B
Net Interest Income	(3.1B)	(3.1B)	(3.0B)	(2.7B)	(2.3B)
Other Non-Op Income/Expense	(2.5B)	(8.2B)	(2.4B)	(2.6B)	(2.1B)
Non-Operating Income (excl Interest)	(601.0M)	5.1B	(590.0M)	(88.0M)	(169.0M)
EBT (Pre-Tax Income)	5.8B	2.1B	6.1B	11.2B	5.8B
Income Tax Expense	916.0M	408.0M	1.6B	2.8B	1.5B
Bottom Line
Net Income	4.9B	1.8B	4.6B	8.3B	4.3B
Earnings from Cont. Ops	4.9B	1.7B	4.6B	8.4B	4.3B
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	4.9B	1.8B	4.6B	8.3B	4.3B
Per Share
Basic EPS	$3.83	$1.40	$3.66	$6.49	$3.29
Diluted EPS	$3.78	$1.39	$3.66	$6.47	$3.26
Revenue Per Share	$325.30	$317.34	$296.12	$278.42	$245.78
Shares
Basic Shares Outstanding	1.3B	1.3B	1.3B	1.3B	1.3B
Diluted Shares Outstanding	1.3B	1.3B	1.3B	1.3B	1.3B
Profitability Metrics
EBITDA	13.4B	9.9B	13.7B	18.2B	12.3B
D&A	4.5B	4.6B	4.6B	4.4B	4.2B
EBIT	8.9B	5.3B	9.1B	13.8B	8.1B

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026